FO
SGYP

FT Options’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

FT Options’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,000
Closed -$70K – 314
2017
Q1 		$70K Buy
+15,000
New +$87K 0.09% 134
2016
Q2 		– Sell
-27,765
Closed -$77K – 436
2016
Q1 		$77K Buy
+27,765
New +$101K 0.08% 139

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FT Options's SGYP Position: Q2 2017 in Review

FT Options sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 15,000 shares — an estimated $70K sold.

FT Options first reported a position in SGYP in Q1 2016 and held it in 2 quarters. The position peaked at $77K in Q1 2016. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

  • FT Options reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
  • FT Options sold 15,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $70K.
  • FT Options first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2016 and held it in 2 quarters.
  • FT Options's Synergy Pharmaceuticals, Inc Common Stock position peaked at $77K in Q1 2016.
  • 146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.